Results 151 to 160 of about 462,338 (258)
Subarachnoid hemorrhage (SAH) triggers monocyte‐derived macrophage (MDM) infiltration and M1‐like polarization via Vimentin upregulation, leading to neurovascular unit disruption and cognitive dysfunction. Remote ischemic postconditioning (RIPostC) upregulates neuronal Gas6, which activates Axl on MDMs to downregulate Vimentin and drive reparative M2 ...
Yajun Zhu +14 more
wiley +1 more source
Perioperative cerebrospinal fluid lactate and glucose changes following intracranial surgery: A prospective observational cohort study. [PDF]
Eryilmaz F.
europepmc +1 more source
A blue‐light‐crosslinked bilayer hydrogel was developed for local optic nerve repair. The adhesive GM‐Odex outer layer seals and anchors the lesion, while the non‐adhesive GM‐imid inner layer releases MPDA‐Cle without obstructing CSF flow. This system modulates oxidative and inflammatory microenvironments, supports oligodendrocyte differentiation and ...
Tonghe Pan +13 more
wiley +1 more source
Paediatric Primary Intracranial Tumours: A 14-year Clinicopathologic Study in North-Central Nigeria. [PDF]
Akpa PO +7 more
europepmc +1 more source
AARS2‐SIRT5‐Driven DLD K445 Lactylation Promotes Cuproptosis Resistance in Glioblastoma Stem Cells
Lactylation of DLD at K445 by AARS2 suppresses PDH complex activity and reduces DLAT lipoylation, thereby conferring cuproptosis resistance in glioblastoma stem cells. SIRT5‐mediated delactylation restores PDH function and enhances cuproptosis sensitivity.
Mingtian Ding +12 more
wiley +1 more source
Treatment of Idiopathic Intracranial Hypertension and the IIHTT
Treatment of raised intracranial pressure is both medical and surgical. It is aimed mainly at lowering of intracranial pressure and secondarily at treating symptoms directly (e.g. headache).
Michael Wall
core
Antibody-drug conjugates in brain metastases: evidence outpacing trial design. [PDF]
Sarfraz Z +3 more
europepmc +1 more source
PLOD1 interacts with ENO1 and limits its FBXW7‐dependent ubiquitination and proteasomal degradation through a mechanism requiring PLOD1 catalytic activity. ENO1 stabilization sustains glycolysis, promoting glioblastoma cell proliferation, migration, and temozolomide resistance.
Fen Xue +4 more
wiley +1 more source
Brain metastasis: Opportunities for novel therapies. [PDF]
Sarfraz Z +3 more
europepmc +1 more source
In this study, we demonstrate that aberrant MEKK3 signaling in endothelial cells and microglia drives the progression of cerebral cavernous malformations (CCMs). Furthermore, we identify DPDH as a potent small‐molecule MEKK3 inhibitor with substantial therapeutic potential for CCM treatment.
Weiwei Zheng +17 more
wiley +1 more source

